Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2024, quý kết thúc ngày Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Vaccinex's ebitda for the twelve months ending Dec 31, 2019 was -$31.77M. For fiscal 2019 it was -$31.77M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -$31.77M | – |
| FY2018 | Dec 31, 2018 | -$27.06M | – |
| FY2017 | Dec 31, 2017 | -$20.90M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | -$6.27M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.61M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.80M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.08M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.50M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.40M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.50M | -114.3% |
| Q1 FY2018 | Mar 31, 2018 | -$5.65M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.14M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.28M | – |
| Q2 FY2017 | Jun 30, 2017 | $45.33M | – |
See a number that looks wrong?